Rezultati - Lièvre, Astrid
- Showing 1 - 20 results of 33
- Go to Next Page
-
1
-
2
-
3
Significant decrease in interval colorectal cancer incidence after implementing immunochemical testing in a multiple-round guaiac-based screening programme od Bretagne, Jean-François, Carlo, Aurore, Piette, Christine, Rousseau, Chloé, Cosson, Mathilde, Lièvre, Astrid
Izdano 2021Text -
4
-
5
-
6
Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy od Gauthé, Mathieu, Richard-Molard, Marion, Rigault, Eugénie, Buecher, Bruno, Mariani, Pascale, Bellet, Dominique, Cacheux, Wulfran, Lièvre, Astrid
Izdano 2018Text -
7
Multidisciplinary team meetings: are all patients presented and does it impact quality of care and survival – a registry-based study od Rollet, Quentin, Bouvier, Véronique, Moutel, Grégoire, Launay, Ludivine, Bignon, Anne-Laure, Bouhier-Leporrier, Karine, Launoy, Guy, Lièvre, Astrid
Izdano 2021Text -
8
Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study od Lièvre, Astrid, Samalin, Emmanuelle, Mitry, Emmanuel, Assenat, Eric, Boyer-Gestin, Christine, Lepère, Céline, Bachet, Jean-Baptiste, Portales, Fabienne, Vaillant, Jean-Nicolas, Ychou, Marc, Rougier, Philippe
Izdano 2009Text -
9
FOLFIRINOX De‐Escalation in Advanced Pancreatic Cancer: A Multicenter Real‐Life Study od Chevalier, Hortense, Vienot, Angélique, Lièvre, Astrid, Edeline, Julien, El Hajbi, Farid, Peugniez, Charlotte, Vernerey, Dewi, Meurisse, Aurélia, Hammel, Pascal, Neuzillet, Cindy, Borg, Christophe, Turpin, Anthony
Izdano 2020Text -
10
Incidental anal (18)fluorodeoxyglucose uptake: Should we further examine the patient? od Moussaddaq, Anne-Sophie, Brochard, Charlène, Palard-Novello, Xavier, Garin, Etienne, Wallenhorst, Timothée, Le Balc’h, Eric, Merlini L’heritier, Alexandre, Grainville, Thomas, Siproudhis, Laurent, Lièvre, Astrid
Izdano 2020Text -
11
Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) od Tougeron, David, Michel, Pierre, Lièvre, Astrid, Ducreux, Michel, Gaujoux, Sébastien, Guiu, Boris, Huguet, Florence, Lecomte, Thierry, Lepage, Côme, Louvet, Christophe, Maggiori, Léon, Mariani, Pascale, Aparicio, Thomas, Bouché, Olivier
Izdano 2021Text -
12
Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma od Lièvre, Astrid, Ouine, Bérèngere, Canet, Jim, Cartier, Aurélie, Amar, Yael, Cacheux, Wulfran, Mariani, Odette, Guimbaud, Rosine, Selves, Janick, Lecomte, Thierry, Guyetant, Serge, Bieche, Ivan, Berger, Frédérique, de Koning, Leanne
Izdano 2017Text -
13
Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma od Lièvre, Astrid, Ouine, Bérèngere, Canet, Jim, Cartier, Aurélie, Amar, Yael, Cacheux, Wulfran, Mariani, Odette, Guimbaud, Rosine, Selves, Janick, Lecomte, Thierry, Guyetant, Serge, Bieche, Ivan, Berger, Frédérique, de Koning, Leanne
Izdano 2018Text -
14
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma od Vary, Antonin, Lebellec, Loïc, Di Fiore, Frédéric, Penel, Nicolas, Cheymol, Claire, Rad, Emilia, El Hajbi, Farid, Lièvre, Astrid, Edeline, Julien, Bimbai, André Michel, Le Deley, Marie-Cécile, Turpin, Anthony
Izdano 2021Text -
15
Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma od Lièvre, Astrid, Milet, Jacqueline, Carayol, Jérôme, Le Corre, Delphine, Milan, Chantal, Pariente, Alexandre, Nalet, Bernard, Lafon, Jacques, Faivre, Jean, Bonithon-Kopp, Claire, Olschwang, Sylviane, Bonaiti-Pellié, Catherine, Laurent-Puig, Pierre
Izdano 2006Text -
16
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study od Zaibet, Sonia, Hautefeuille, Vincent, Auclin, Edouard, Lièvre, Astrid, Tougeron, David, Sarabi, Mathieu, Gilabert, Marine, Wasselin, Julie, Edeline, Julien, Artru, Pascal, Bechade, Dominique, Morin, Clémence, Ducoulombier, Agnes, Taieb, Julien, Pernot, Simon
Izdano 2022Text -
17
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study od Zaibet, Sonia, Hautefeuille, Vincent, Auclin, Edouard, Lièvre, Astrid, Tougeron, David, Sarabi, Mathieu, Gilabert, Marine, Wasselin, Julie, Edeline, Julien, Artru, Pascal, Bechade, Dominique, Morin, Clémence, Ducoulombier, Agnes, Taieb, Julien, Pernot, Simon
Izdano 2022Text -
18
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study od Javed, Sahir, Benoist, Stéphane, Devos, Patrick, Truant, Stéphanie, Guimbaud, Rosine, Lièvre, Astrid, Sefrioui, David, Cohen, Romain, Artru, Pascal, Dupré, Aurélien, Bachet, Jean-Baptiste, de la Fouchardière, Christelle, Ploquin, Anne, Turpin, Anthony
Izdano 2022Text -
19
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) od Di Fiore, Frederic, Bouché, Olivier, Lepage, Come, Sefrioui, David, Gangloff, Alice, Schwarz, Lilian, Tuech, Jean Jacques, Aparicio, Thomas, Lecomte, Thierry, Boulagnon-Rombi, Camille, Lièvre, Astrid, Manfredi, Sylvain, Phelip, Jean Marc, Michel, Pierre
Izdano 2020Text -
20
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial od Edeline, Julien, Touchefeu, Yann, Guiu, Boris, Farge, Olivier, Tougeron, David, Baumgaertner, Isabelle, Ayav, Ahmet, Campillo-Gimenez, Boris, Beuzit, Luc, Pracht, Marc, Lièvre, Astrid, Le Sourd, Samuel, Boudjema, Karim, Rolland, Yan, Boucher, Eveline, Garin, Etienne
Izdano 2019Text